Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 247

Netcore acquires Quinto.ai after pivot

Rebel Foods has exited chatbot developer Quinto Technologies in an acquisition of undisclosed size by Netcore Solutions.

Apr 22, 2019

Reali locks in Lenda acquisition

Reali will onboard the company's technology to create an online mortgage application platform following the acquisition, which allowed CreditEase Fintech Investment Fund to exit.

Apr 19, 2019

Twitter draws up Highly acquisition

Bloomberg Beta has exited online text highlighting tool developer Highly in an acquisition of undisclosed size by Twitter.

Apr 19, 2019

Pinterest hits NYSE in $1.4bn IPO

Qualcomm-backed visual social media platform Pinterest floated above its range in an offering that will give it a market cap near $13bn.

Apr 18, 2019

Zoom crashes into public markets with $751m

Zoom is floating above its range in an IPO in which Qualcomm will make an immediate $30.6m return, while Salesforce is buying $100m of shares through a private placement.

Apr 18, 2019

Salesforce locates MapAnything for acquisition deal

Salesforce has agreed to buy the location services provider in a deal that will hand exits to fellow corporate investors ServiceNow and General Motors.

Apr 18, 2019

Gyroscope enters Orbit for merger

Gyroscope Therapeutics, spun out of Cambridge and Syncona, has merged with Orbit Biomedical to form a fully-integrated retinal gene therapy developer.

Apr 18, 2019

Sonim sounds out Nasdaq for IPO

Outdoor electronic goods producer Sonim Technologies has filed for a $57.5m initial public offering that would provide exits for Motorola Solutions and JVC Kenwood.

Apr 18, 2019

Turning Point directs itself to $167m IPO

Eli Lilly and GSK-backed precision oncology drug developer Turning Point Therapeutics floated at the top of its range while expanding the number of shares it issued.

Apr 17, 2019

Applied Therapeutics pushes for public markets

Alexandria Real Estate Equities-backed molecular therapy developer Applied Therapeutics is aiming for $86.3m in its initial public offering.

Apr 17, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here